Literature DB >> 27561956

Patient Selection and Timing of Continuous Renal Replacement Therapy.

Marlies Ostermann1, Michael Joannidis, Antonello Pani, Matteo Floris, Silvia De Rosa, John A Kellum, Claudio Ronco.   

Abstract

When and in whom to initiate continuous renal replacement therapy (CRRT) for acute kidney injury (AKI) remains a highly controversial topic with large practice variation around the world. Even within countries, practice variation exists and recommendations for clinical practice are not specific. In this article, we report the consensus recommendations for timing and patient selection for CRRT - the results of the 2016 Acute Disease Quality Initiative XVII conference on 'precision CRRT'. We suggest that these recommendations could serve to develop the best clinical practice and standards of care for use of CRRT in patients with AKI. Finally, we identify and highlight the areas of ongoing uncertainty and propose an agenda for future research.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27561956     DOI: 10.1159/000448506

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  34 in total

1.  ACUsmart Continuous Renal Replacement Therapy Platform: Multicenter Pilot Study for Technical and Clinical Assessment (A.M.P. Study).

Authors:  Mauro Neri; Anna Lorenzin; Massimo de Cal; Alessandra Brendolan; Nicola Marchionna; Sara Samoni; Monica Zanella; Silvia De Rosa; Francesca Martino; Zaccaria Ricci; Javier Maynar; Georg Auzinger; Gianluca Villa; Didier Payen; Michael Joannidis; Claudio Ronco
Journal:  Blood Purif       Date:  2019-02-01       Impact factor: 2.614

2.  Timing of Kidney Replacement Therapy in Acute Kidney Injury.

Authors:  Alexander Zarbock; Ravindra L Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-30       Impact factor: 8.237

3.  Guiding Physician Decisions for Initiating Dialysis for AKI: Is Progress on the Horizon?

Authors:  Etienne Macedo; Ravindra L Mehta
Journal:  Clin J Am Soc Nephrol       Date:  2017-01-24       Impact factor: 8.237

4.  Timing of RRT initiation in critically-ill patients: time for precision medicine.

Authors:  Eric Kipnis; Francesco Garzotto; Claudio Ronco
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

5.  Providing Continuous Renal Replacement Therapy in Patients on Extracorporeal Membrane Oxygenation.

Authors:  Nithin Karakala; Luis A Juncos
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 8.237

Review 6.  Sepsis: frontiers in supportive care, organisation and research.

Authors:  Anders Perner; Andrew Rhodes; Bala Venkatesh; Derek C Angus; Ignacio Martin-Loeches; Jean-Charles Preiser; Jean-Louis Vincent; John Marshall; Konrad Reinhart; Michael Joannidis; Steven M Opal
Journal:  Intensive Care Med       Date:  2017-01-27       Impact factor: 17.440

Review 7.  Fluid management in acute kidney injury.

Authors:  Anders Perner; John Prowle; Michael Joannidis; Paul Young; Peter B Hjortrup; Ville Pettilä
Journal:  Intensive Care Med       Date:  2017-05-03       Impact factor: 17.440

Review 8.  [Renal replacement therapy in acute kidney injury].

Authors:  S J Klein; M Joannidis
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05-02       Impact factor: 0.840

Review 9.  [Extracorporeal renal replacement therapy in acute kidney injury : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Authors:  V Schwenger; D Kindgen-Milles; C Willam; A Jörres; W Druml; D Czock; S J Klein; M Oppert; M Schmitz; J T Kielstein; A Zarbock; M Joannidis; S John
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-03-15       Impact factor: 0.840

10.  Optimal timing of renal replacement therapy in patients with acute kidney injury in the context of sepsis : Discussion on "Sepsis: frontiers in supportive care, organisation and research".

Authors:  Stéphane Gaudry; David Hajage; Didier Dreyfuss; Michael Joannidis; Anders Perner
Journal:  Intensive Care Med       Date:  2017-07-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.